Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Immunogenicity & Safety of a Commercially Available Vaccine co-Administered With GSK HPV Vaccine (580299)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				20 to 25				Pharmaceutical / Industry				111567 NCT00637195


2.		Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine co-Administered With Another Vaccine in Healthy Female Subjects

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Prevention				Closed				9 to 15				Pharmaceutical / Industry				111507 NCT00652938


3.		Modified Process Hepatitis B Vaccine in Healthy Neonates

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Prevention				Completed				10 days and under				Pharmaceutical / Industry				2006_007 V232-056, NCT00322361

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute